Who owns Denali Therapeutics Inc (DNLI)? Superinvestor holders
4 superinvestors of the 157 tracked here hold Denali Therapeutics Inc (DNLI) in their latest 13F filing, with $571.3M between them. Julian and Felix Baker gives it the most weight: 0.48% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker and Brandon Haley added; Baillie Gifford team reduced.
Key facts
- Superinvestors holding it
- 4 of 157
- Biggest holder
- Baillie Gifford team, $229.8M
- Largest weight
- Julian and Felix Baker, 0.48%of their portfolio
- Combined value
- $571.3M
- Bought last quarter
- 2
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Julian and Felix BakerBaker Bros. Advisors | 0.48% | $96M | 3.73M | ▲ Added 0.07% | +2.61K | Q2 2026 |
| 2 | TemasekTemasek Holdings | 0.40% | $145M | 7.01M | No change | 0 | Q3 2026 |
| 3 | Brandon HaleyHolocene Advisors | 0.23% | $100.4M | 3.91M | ▲ Added 22% | +709.72K | Q2 2026 |
| 4 | Baillie Gifford teamBaillie Gifford & Co | 0.22% | $229.8M | 11.12M | ▼ Reduced 7.0% | −840.84K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 18.13M | $374.8M | 0 | 1 |
| Q2 2026 | 157 | 4 | 26.61M | $684.5M | 2 | 2 |
| Q1 2026 | 157 | 4 | 22.88M | $439.2M | 1 | 1 |
| Q4 2025 | 157 | 3 | 23.06M | $380.6M | 2 | 0 |
| Q3 2025 | 157 | 3 | 20.68M | $300.3M | 0 | 1 |
| Q2 2025 | 157 | 3 | 21.04M | $294.4M | 0 | 1 |
| Q1 2025 | 156 | 3 | 21.18M | $287.9M | 0 | 1 |
| Q4 2024 | 156 | 3 | 21.4M | $436.2M | 0 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Baillie Gifford team | 11.12M | 11.96M | 12.07M | 12.31M | 11.59M | 11.96M | 12.09M | 12.31M |
| Temasek | 7.01M | 7.01M | 7.01M | 7.01M | 5.36M | 5.36M | 5.36M | 5.36M |
| Brandon Haley | · | 3.91M | — | — | — | — | — | — |
| Julian and Felix Baker | · | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M |
| Polen Capital team | — | — | 65.3K | — | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own DNLI?
In their latest 13F filings: Julian and Felix Baker (0.48% of the portfolio, $96M), Temasek (0.40% of the portfolio, $145M), Brandon Haley (0.23% of the portfolio, $100.4M), Baillie Gifford team (0.22% of the portfolio, $229.8M).
Who bought DNLI last quarter?
Julian and Felix Baker (added 0.1%), Brandon Haley (added 22%). “Last quarter” is each investor's latest reported quarter.
Who sold DNLI last quarter?
Reduced: Baillie Gifford team (7.0% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Denali Therapeutics Inc (DNLI)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DNLI/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DNLI by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.